Dimo Dietrich

SHOX2 DNA Methylation Is a Biomarker for the Diagnosis of Lung Cancer in Plasma

Christoph Kneip, Bernd Schmidt, Anke Seegebarth et al. · Journal of Thoracic Oncology · 2011 · 266 citations

Shox2 Dna Methylation, Medicine, Epigenetic Change +10

The Immune Checkpoint Regulator PD-L1 Is Highly Expressed in Aggressive Primary Prostate Cancer

Heidrun Gevensleben, Dimo Dietrich, Carsten Golletz et al. · Clinical Cancer Research · 2015 · 230 citations

SHOX2 DNA Methylation is a Biomarker for the diagnosis of lung cancer based on bronchial aspirates

Bernd Schmidt, Volker Liebenberg, Dimo Dietrich et al. · BMC Cancer · 2010 · 196 citations · Full text

CD155 on Tumor Cells Drives Resistance to Immunotherapy by Inducing the Degradation of the Activating Receptor CD226 in CD8+ T Cells

Matthias Braun, Amelia Roman Aguilera, Ashmitha Sundarrajan et al. · Immunity · 2020 · 169 citations · Full text

Tumor Immunology, Cancer Immunosurveillance, Activating Receptor Cd226 +9

Performance Evaluation of Kits for Bisulfite-Conversion of DNA from Tissues, Cell Lines, FFPE Tissues, Aspirates, Lavages, Effusions, Plasma, Serum, and Urine

Emily Eva Holmes, Maria Jung, Sebastian Meller et al. · PLoS ONE · 2014 · 153 citations · Full text

Bisulfite Conversion, Engineering, Dna Methylation +20